FLUOROURACIL ALPHAPHARM fluorouracil 2.5 g/50 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil alphapharm fluorouracil 2.5 g/50 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL AGILA fluorouracil 500 mg/10 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil agila fluorouracil 500 mg/10 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL AGILA fluorouracil 5 g/100 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil agila fluorouracil 5 g/100 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL AGILA fluorouracil 1000 mg/20 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil agila fluorouracil 1000 mg/20 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL MYLAN fluorouracil 2.5 g/50 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil mylan fluorouracil 2.5 g/50 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 2.5 g - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL AGILA fluorouracil 2.5 g/50 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil agila fluorouracil 2.5 g/50 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL MYLAN fluorouracil 500 mg/10 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil mylan fluorouracil 500 mg/10 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 500 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL MYLAN fluorouracil 1000 mg/20 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil mylan fluorouracil 1000 mg/20 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL MYLAN fluorouracil 5 g/100 mL solution for injection vial Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fluorouracil mylan fluorouracil 5 g/100 ml solution for injection vial

medtas pty ltd - fluorouracil, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the,breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine,(cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered,impractical.

FLUOROURACIL INJECTION SOLUTION Kanada - Kiingereza - Health Canada

fluorouracil injection solution

sandoz canada incorporated - fluorouracil - solution - 50mg - fluorouracil 50mg - antineoplastic agents